COLLEEN JEWESS: Open Payments
NPI 1013591890 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 19 payments from 10 companies in 2025. Trend: 2023 $1,293 · 2024 $2,653 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $137 |
| Janssen Biotech, Inc. | 4 | $78 |
| GENZYME CORPORATION | 2 | $60 |
| LEO Pharma Inc. | 2 | $56 |
| Amgen Inc. | 2 | $53 |
| Organon LLC | 1 | $32 |
| ABBVIE INC. | 1 | $28 |
| Incyte Corporation | 1 | $23 |
| STRATA Skin Sciences, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
Products named: LITFULO, TREMFYA, DUPIXENT, ADBRY, Otezla, VTAMA, CIBINQO, SKYRIZI.
Industry payments across CA — which companies pay providers there.
